Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Gilead's 2026 Outlook Falls Short of Wall Street Expectations, Stock Price Drops

Gilead's 2026 Outlook Falls Short of Wall Street Expectations, Stock Price Drops

新浪财经新浪财经2026/02/10 23:29
Show original
By:新浪财经

Gilead Sciences released its 2026 financial forecast on Tuesday, which was at the lower end of analysts' expectations, including sales of its groundbreaking twice-yearly injectable HIV prevention drug, causing its stock price to fall by nearly 2%.

The California-based biotechnology company also reported fourth-quarter 2025 sales and profits that slightly exceeded Wall Street expectations. Quarterly sales of Yeztugo, the twice-yearly injectable HIV prevention drug launched in the U.S. last year, totaled $96 million, surpassing Wall Street's forecast of $88 million. Gilead stated it expects Yeztugo sales to reach $800 million in 2026, while analysts had predicted $907 million. Brian Abrahams, an analyst at RBC Capital Markets, said Yeztugo's forecast is "below investors' 'whisper' expectation of $1 billion." The drug has been shown in clinical trials to be nearly 100% effective in preventing HIV, offering new hope for blocking the virus that infects 1.3 million people globally each year. However, some are hesitant about Yeztugo's U.S. launch price of about $28,000 per year. Gilead said that so far, 90% of U.S. payers have agreed to cover the drug. Gilead also said it expects adjusted earnings per share in 2026 to be between $8.45 and $8.85. Analysts had anticipated earnings per share of $8.75, $0.10 higher than Gilead’s forecast midpoint. Gilead’s stock fell 3% in regular trading and dropped about 2% after hours, closing at $144.52.

Editor: Wang Yongsheng

0
1

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

As security concerns heat up, NVIDIA (NVDA.US) introduces engineering responses! Dual-layer AI security platform directly addresses agent permissions and abnormal behaviors.

Nvidia has launched a dual-layer AI security platform called the "Open Agent Safety Platform." Through a three-tier architecture—application layer, runtime, and infrastructure—it provides AI agents with continuous monitoring, real-time policy enforcement, and security governance.

智通财经•2026/09/28 11:31